Dr. Reddy's Laboratories
RDY
S$18.91
Share price
0.20%
Change (1 day)
-14.16%
Change (1 year)
Categories
Dr. Reddy's Laboratories (RDY) - P/B ratio
P/B ratio as of July 2025 : 3.13
According to Dr. Reddy's Laboratories's latest financial reports the company has a price-to-book ratio of 3.20553.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Dr. Reddy's Laboratories - P/B ratio (from 2001 to 2025)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2025-12-31 | N/A | -100% |
| 2024-12-31 | 3.59 | -0.93% |
| 2023-12-31 | 3.63 | 12.3% |
| 2022-12-31 | 3.23 | -24.69% |
| 2021-12-31 | 4.29 | -15.54% |
| 2020-12-31 | 5.08 | 58.75% |
| 2019-12-31 | 3.20 | -0.02% |
| 2018-12-31 | 3.20 | -0.93% |
| 2017-12-31 | 3.23 | -22.95% |
| 2016-12-31 | 4.19 | 1.86% |
| 2015-12-31 | 4.11 | -21.78% |
| 2014-12-31 | 5.26 | 3.95% |
| 2013-12-31 | 5.06 | 8.79% |
| 2012-12-31 | 4.65 | -9.51% |
| 2011-12-31 | 5.14 | -12.02% |
| 2010-12-31 | 5.84 | 22.8% |
| 2009-12-31 | 4.75 | 215.25% |
| 2008-12-31 | 1.51 | -43.4% |
| 2007-12-31 | 2.66 | -24.06% |
| 2006-12-31 | 3.51 | 6.03% |
| 2005-12-31 | 3.31 | -0.36% |
| 2004-12-31 | 3.32 | -37.28% |
| 2003-12-31 | 5.30 | 36.07% |
| 2002-12-31 | 3.89 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 1.52 | -51.21% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 3.02 | -3.36% | 🇮🇱 Israel |
 GlaxoSmithKline GSK | 4.29 | 37.12% | 🇬🇧 UK |
 Novartis NVS | 5.85 | 87.15% | 🇨🇭 Switzerland |
 Sanofi SNY | 1.50 | -52.13% | 🇫🇷 France |